Novo-Nordisk

Study puts first total on diabetes cost: $218 billion, including medical and indirect costs

By LINDA A. JOHNSON , Associated Press TRENTON, N.J. - A new study, released Tuesday exclusively to The Associated Press, puts the total at $218 billion last year — the first comprehensive estimate of the financial toll...

Will Carl Icahn Come to Amylin's Rescue? (at Seeking Alpha)

by: Mike Huckman November 18, 2008 | about stocks: ). At the end of June he held nearly 7,000,000 shares of AMLN. AMLN has been hammered by safety concerns over the diabetes drug, Byetta, which it shares with Eli Lilly , by...

Learn about the World Biotechnology Market Brief (Business Wire)

Tuesday November 18, 8:27 am ET NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. Market (2003):...

China Biotech in Review: Earnings Week (at Seeking Alpha)

by: ChinaBio Today November 17, 2008 | about stocks: Last week was the quarterly high watermark for earnings announcements in China Biotech. As a basic theme, the reports seemed each in their own way to reiterate the same...

Denmark: Antyra signs licensing agreement with Novo Nordisk

TendersInfo - Nov. 15, 2008 Antyra, a biotechnology company, has entered into a global licensing agreement with Novo Nordisk, a healthcare company, for IGF-related antagonists for the treatment of cancer and other...

Survey Reports Young Adults With Type 1 Diabetes Need More Social And Psychological Support

Data from a new global survey released on World Diabetes Day finds that many teens and young adults with type 1 diabetes are optimistic about their future, but report a lack of support from school staff. The poll highlights the...

Novo Nordisk organizes Diabetes Walk in Bangalore

Our Bureau, Bangalore Novo Nordisk, the world leader in diabetes care, organized a Diabetes Walk at the Cubbon Park, in Bangalore on the occasion of United Nations mandated World Diabetes Day, observed annually on November 14....

Amylin Facing Crisis of Confidence (at Seeking Alpha)

by: EP Vantage November 14, 2008 | about stocks: ) valuation over the last few months indicates a serious collapse in confidence in the group as a whole, and with a focus on diabetes and obesity, two of the most challenging...

Antyra signs licensing agreement with Novo Nordisk

Nov 13, 2008 (Datamonitor via COMTEX) -- -- Antyra, a biotechnology company, has entered into a global licensing agreement with Novo Nordisk, a healthcare company, for IGF-related antagonists for the treatment of cancer and...

Best Practice Database Provides Key Findings for Biopharma Product Launch Evaluation

More News related to Press Releases CHAPEL HILL, N.C., Nov. 13 /PRNewswire/ -- Bio-Pharma executives are increasingly finding value in the research products and services offered by Best Practices, LLC and in particular in use...

1 2 3 4 5 next »